BioNTech ist ein Biotechunternehmen, das sich auf die Entwicklung von Immuntherapien zur Behandlung von Krebs und anderen schweren Krankheiten spezialisiert hat. Der Firmensitz befindet sich in Mainz, der Börsengang erfolgte im Oktober 2019 an der Nasdaq.
COMPANY
INVESTOR TERMSHEET
22UA
BioNTech
#BGFL Mood:
-
·
#BGFL-Indicator:
-
·
Review date:
-
LEI:
894500UZJ5LG1F8J1U58
SECTOR:
Gesundheit
SUB-SECTOR:
Biotechnologie
BioNTech
A2PSR2
US09075V1026
22UA
Xetra
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL